03026nam 22007814a 450 991080877800332120200520144314.00-19-770572-30-19-045136-X1-281-82598-097866118259800-19-970933-510.1093/oso/9780195368741.001.0001(CKB)1000000000553679(EBL)415113(OCoLC)476240107(SSID)ssj0000109718(PQKBManifestationID)11142810(PQKBTitleCode)TC0000109718(PQKBWorkID)10059561(PQKB)10487269(Au-PeEL)EBL415113(CaPaEBR)ebr10254460(CaONFJC)MIL182598(MiAaPQ)EBC415113(OCoLC)1406781409(StDuBDS)9780197705728(OCoLC) 212399908(FINmELB)ELB165853(EXLCZ)99100000000055367920080220d2009 uy 0engur|n|---|||||txtccrBefore Prozac the troubled history of mood disorders in psychiatry /Edward Shorter1st ed.Oxford ;New York Oxford University Press20091 online resource (321 p.)Oxford scholarship onlinePreviously issued in print: 2008.0-19-536874-6 Includes bibliographical references and index.Before psychopharmacology -- The first drug set -- Power play -- Killer drugs! -- Death sentences -- "The plague of affective disorders" -- Losing ground -- What now?In this volume, Shorter presents a revealing account of why psychiatry is 'losing ground' in the struggle to treat depression. It focuses on an unexpected villain - the FDA, the very agency charged with ensuring drug safety and effectiveness. Shorter describes how the FDA permits companies to test new products only against placebo.Oxford scholarship online.Affective disordersChemotherapyUnited StatesHistoryPsychotropic drugsUnited StatesHistoryPsychopharmacologyUnited StatesHistorySerotonin uptake inhibitorsTherapeutic useHistoryPsychotropic drugs industryUnited StatesHistoryPharmaceutical policyUnited StatesHistoryAffective disordersChemotherapyHistory.Psychotropic drugsHistory.PsychopharmacologyHistory.Serotonin uptake inhibitorsTherapeutic useHistory.Psychotropic drugs industryHistory.Pharmaceutical policyHistory.616.85/27061Shorter Edward128248MiAaPQMiAaPQMiAaPQBOOK9910808778003321Before Prozac4095746UNINA